About Dr. Adnan Qureshi

Dr. Adnan is a distinguished researcher and medical professional specializing in neurology and cardiovascular clinical medicine. He has achieved global recognition, ranking in the top 2% of researchers in 2022 based on his C score in Neurology/Cardiovascular/Clinical Medicine. His notable positions and accomplishments include:

  • Co-Director of Toshiba Stroke Research at the University at Buffalo (2001-2002), overseeing funded research projects and receiving an AHA award for stroke care studies.
  • Director of the Cerebrovascular Program at the University of Medicine and Dentistry of New Jersey (2002-2006), establishing fellowship programs and leading stroke program initiatives.
  • Executive Director of the Minnesota Stroke Initiative (2006-2012), gaining regional, national, and international recognition for stroke care, achieving stroke center certification for two hospitals, and initiating NIH and AHA funded stroke research.
  • Vice Chair of the Department of Neurology (2006-2012), contributing to faculty recruitment, policy development, and budget planning.
  • Chair of the Cerebrovascular Program at CentraCare Health (2013-2015), overseeing fellowship programs and collaborating on the development of a telestroke program.
  • First President of the Society of Vascular and Interventional Neurology (2007-2008) and the International Society of Interventional Neurology (2012-2019), establishing these leading global societies.
  • Principal Investigator of the Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)2 study (2010-2015), managing a multicenter trial conducted in seven countries and 150 centers.
  • Founder of Zeenat Qureshi Stroke Institutes, conducting cutting-edge research on cerebrovascular diseases in multiple countries.
  • Co-founder of AQURE Medical, a company producing intracranial medical catheters in China.
  • Program Director of the Endovascular Surgical Neuroradiology program at the University of Missouri, Columbia (2018-present), overseeing fellowship programs and participating in faculty recruitment and budget planning.
  • Professor in the Department of Neurology at the University of Missouri, Columbia (2017-present), actively involved in departmental and institutional committees.
  • Chair of the Interventional Neurology Program Requirements Task Force for the UCNS subspecialty of Interventional Neurology (2020-2021).

Dr. Adnan's expertise, research contributions, and leadership positions have made him a prominent figure in the field of neurology and cardiovascular clinical medicine.